{
  "id": "ecb7772a05299cc9",
  "title": "Epkinly Plus Rituximab / Lenalidomide Approved for R / R Follicular Lymphoma",
  "description": "20251223T183000Z",
  "content": "",
  "source": "cancertherapyadvisor.com",
  "source_url": "https://www.cancertherapyadvisor.com/news/epkinly-plus-rituximab-lenalidomide-approved-for-r-r-follicular-lymphoma/",
  "published_at": "20251223T183000Z",
  "fetched_at": "2025-12-24T00:22:47.431682+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.cancertherapyadvisor.com/news/epkinly-plus-rituximab-lenalidomide-approved-for-r-r-follicular-lymphoma/",
    "url_mobile": "",
    "title": "Epkinly Plus Rituximab / Lenalidomide Approved for R / R Follicular Lymphoma",
    "seendate": "20251223T183000Z",
    "socialimage": "https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2024/01/CTA_1200x675.png",
    "domain": "cancertherapyadvisor.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}